The psychobiology of depression;Uberlegungen zur Psychobiologie der Depression

Nervenarzt

Volumn 68, Issue 5, 1997, Pages 379-389

  Aldenhoff, J ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

corticosteroids; interpersonal psychotherapy; learned helplessness; neurobiology; pharmacotherapy

Indexed keywords

DEPRESSION; HUMAN; PSYCHOBIOLOGY; REVIEW;

ANTIDEPRESSIVE AGENTS; BRAIN; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; HELPLESSNESS, LEARNED; HUMANS; NEUROTRANSMITTER AGENTS; PSYCHOTHERAPY, BRIEF; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 0030997370     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050139     Document Type: Review

References (96)

1. Adrien J, Dugovic C, Martin P (1991) Sleep-wakefulness patterns in the helpless rat. Physiol Behav 49:257-262
2. Aghajanian GK, Rogawski MA (1983) The physiological role of alpha-adrenoceptors in the CNS: new concepts from single-cell studies. TIPS 315-317
3. Aghajanian GK, Vandermaelen CP, Andrade R (1983) Intracellular studies on the role of calcium in regulating the activity and reactivity of locus coeruleus neurons in vivo. Brain Res 273:237-243
4. Aldenhoff JB, Dumais-Huber C (1996) Biological changes after psychotherapeutic or pharmacotherapeutic treatment of depression. Eur Arch Psychiatry Clin Neurosci (in press)
5. Aldenhoff JB, Fritze J (1996) Antidepressiva. Psychopharmakotherapie 2 77-80
6. Aldenhoff JB, Dumais-Huber C, Fritzsche M, Sulger J, Vollmayr B (1996) Altered calcium-homeostasis in single T-lymphocytes of depressed patients. J Psychiat Res (in press)
7. Aldenhoff JE, Gruol DL, Rivier J, Vale W, Siggins GR (1983) Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221:875-877
8. Aldenhoff JB, Hennig S (1988) Corticosterone hyperpolarizes pyramidal neurons of the hippocampus in vitro. Soc Neurosci Abstr. 178.4
9. Axelrod J (1963) The formation, metabolism, uptake and release of Noradrenaline and Adrenaline. In:Varley H, Gowenlock AH (eds) The clinical chemistry of monoamines. Elsevier, Amsterdam
10. Bardeleben U v, Holsboer F, Stalla G, Muller OA (1985) Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci 37:1613-1618
11. Beck A, Rush A, Shaw B, Emery G (1986) Kognitive Therapie der Depression. Psychologie Verlags Union, Munchen
12. Berger M, Riemann D, Hochli D, Spiegel R (1989) The cholinergic REM-sleep induction test with RS 86: state- or traitmarker of depression? Arch Gen Psychiatry 46:421-428
13. Bloom FE, Battenberg ELF, Rivier RJ, Vale W (1982) Corticotropin releasing factor (CRF): immunoreactive neurons and fibers in rat hypothalamus. Regul Pept 3 43-48
14. Bowlby J (1979) The making and breaking of affectional bonds. Tavistock, London
15. Bondy B, Ackenheil M, Muller-Spahn F (1988) Biologische Marker endogener Psychosen. Nervenarzt 59:565-572
16. van Calker D, Forstener U, Bohus M, Gebicke-Harter P, Hecht H, Wark HJ, Berger M (1993) Increases sensitivity to agonist stimulation of the Ca2+ response in neutrophils of manic-depressive patients: effects of lithium therapy. Neuropsychobiology 27:180-183
17. Carlsson A, Lindquist M, Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as reserpine antagonists. Nature 180:1200
18. Carroll BJ, Feinberg M, Greden JF, Taríka J, Albala AA, Haskett RF, James N, Kronfol Z, Lohr N, Steiner M, De Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38:15-22
19. Degkwitz R, Frowein R, Kulenkampff C, Mohs U (1960) The influence of reserpine, chlorpromazine, iproniazid and vitamin B6 on the effects of L-dopa in man. Klin Wochenschr 38:120-123
20. DeKloet ER, Reul JMHM, Sutano W (1990) Corticosteroids and the brain. J Steroid Biochem Mol Biol 37:387-394
21. Delgado PL, Price LH, Miller RM, Salomon RM, Aghajanian GK, Heninger GR, Charney DS (1994) Serotonin and the neurobiology of depression. Arch Gen Psychiatry 51 865-874
22. Edwards E, Harkins K, Wright G, Henn FA (1991) 5-HT-sub(1b) receptors in an animal model of depression. Neuropharmacology 30:101-105
23. Ehlers CL, Henriksen SJ, Wang M, Rivier J,Vale M, Bloom FE (1983) Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res 278.332-336
24. Elkin I, Shea T, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB (1989) National institute of mental health treatment of depression collaborative research program. Arch Gen Psychiatry 46:971-982
25. Esser G, Schmidt MH, Blanz B (1993) Der Einfluß von Zeitpunkt und Chronizrtät von Stressoren auf die seelische Entwicklung von Kindern und Jugendlichen. Z Kinder Jugendpsychiatr 21:82-89
26. Faucett RL (1958) Induced depressions: pharmacologic effects. Am J Psychiatry 115:247-248
27. Fisher LA, Jessen G, Brown MR (1983) Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate. Regul Pept 5:153-161
28. Frank E, Kupfer DJ, Perel JM (1990) Three year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099
29. Geoffroy M, Tvede K, Christensen AV, Schou JS (1991) The effect of imipramine and lithium on "learned helplessness" and acetylcholinesterase in rat brain. Pharmacol Biochem Behav 38:93-97
30. Giral P, Martin P, Soubrie P, Simon P (1988) Reversat of helpless behavior in rats by putative 5-HT-sub (1A) agonists. Biol Psychiatry 23:237-242
31. Greden JF (1993) Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry 54:39-45
32. Greenberg L, Edwards E, Henn FA (1989) Dexamethasone suppression test in helpless rats. Biol Psychiatry 26:530-532
33. Gross-Iserhoff R, Dillon KA, Israeli M, Biegon A (1990) Regionally selective increases in Mu opiate receptor density in the brains of suicide victims. Brain Res 530:312-316
34. Guillemin R (1981) Hypothalamic hypophysiotrophic peptides, known and unknown. J Endocr 90:3-10
35. Henn F (1996) The psychobiology of depression; data from animal models. In: Hafner H, Wolpert EM (eds) New research in psychiatry. Hofgrefe & Huber
36. Hellhammer DH, Rea MA, Bell L, Belkien L, Ludwig M (1984) Learned helplessness: effects of brain monoamines and the pituitary gonadal axis. Pharmacol Biochem Behav 21:481-485
37. Heuser IJE,Wark HJ, Keul J, Holsboer F (1991) Hypothalamic-prtuitary-adrertal axis function in elderly endurance athletes. J Clin Endocr Metab 73 485-488
38. Hirschfeld RMA (1994) Guidelines for the long-term treatment of depression. J Clin Psychiatry 55:61-69
39. Holsboer F (1983) Prediction of clinical course by dexamethasone suppression test response in depressed patients - physiological and clinical construct validity of the DST. Pharmacopsychiatry 16.186-191
40. Holsboer F (1989) Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity. Eur Arch Psychiatry Neurol Sci 238 302-322
41. Holsboer F, Muller OA, Doerr HG, Sipell WG, Stalla GK, Gerken A, Steiger A, Boll E, Benkert O (1984) ACTH and multisteroid responses to CRF in depressive illness. Psychoneuroendocrinology 9:147-160
42. Janowsky DS, ElYousef MK, Davis JM, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632-635
43. Keller MB, Lavon PW, Mueller TI (1992) Time of recovery, chronicity, and levels of psydiopathology in major depression: a 5 year prospective follow-up of 431 subjects. Arch Gen Psychiatry 49 809-816
44. Klerman G, Weissman MM, Rounsaville BJ, Chevron ES (1984) Interpersonal psychotherapy of depression. Basic Books, New York
45. Kramer P (1993) Listening to prozac. Viking
46. Krieg JC, Lauer CJ, Hermle L, von Bardeleben U, Pollmacher T, Holsboer F (1990) Psychometric, polysomnographic, and neuroendocrine measures in subjects at high risk for psychiatric disorders: preliminary results. Neuropsychobiology 23.57-67
47. Kuhn R (1958) The treatment of depressive states with G 22355 (imipramine hyodrochloride). Am J Psychiatry 115.459-464
48. Kupfer DJ, Frank E, Perel JM et al. (1992) Five-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49:769-773
49. Kupfer DJ, Frank E, Wamhoff J (1995) Mood disorders: update on prevention of recurrence. In: Mundt C, Goldstein M, Hahlweg K, Fiedler P (eds) Interpersonal factors in origin and course of affective disorders. Gaskell, London
50. Laudenslager ML, Fleshner M, Hofstadter P, Held PE et al (1988) Suppression of specific antibody production by inescapable shock: stability under varving conditions. Brain Behav Immun 2:92-101
51. Leonard BE (1991) Antidepressants, current concepts of mode of action. Encephale 17:127-131
52. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res Mol Brain Res 17:31-35
53. Maier-Steven F, Laudenslager ML (1988) Inescapable shock, shock controllability, and mitogen stimulated lymphocyte proliferation. Brain Behav Immun 2:87-91
54. Maier W, Hallmayer J, Lichtermann D, Philipp M, Klingler T (1991) The impact of the endogenous subtype on the familial aggregation of unipolar depression. Eur Arch Psychiatry Clin Neurosci 240:355-362
55. Martin P, Edwards E, Johnson JOP, Henn FA (1990a) Monoamine receptors in an animal model of affective disorder. J Neurochem 55:1142-1148
56. Martin P, Soubrie P, Puech AJ (1990b) Reversal of helpless behavior by serotonin uptake blockers in rats. Psychopharmacology 101:403-407
57. Maturana HR, Varela F (1987) Der Baum der Erkenntnis. Scherz, Bern Munchen
58. Mayberg US, Danrals RF, Ross CA, Wilson AA, Ravert HT, Frost JJ (1991) Mu opiate receptor binding is increased in depressed patients by PET and C-carfentinol. Am Coll Neuropsychopharmacol Abstr, 30th Annual Meet, p 61
59. McFarlane (1994) Individual psychotherapy for post-traumatic stress disorder. Psychiat Clin North Am 17.393-408
60. Meaney MJ, Aitken DH, Bhatnagar S, Sapolsky RM (1991) Postnatal handling attenuates certain neuroendocrine, anatomical, and cognitive dysfunctions associated with aging in female rats. Neurobiol Aging 12:31-38
61. 60a. Montgomery S (1993) Personal communication, ACNP-meeting
62. Montkowski A, Holsboer F (1996) Transgene Tiermodelle in der psychiatrischen Forschung. Neuroforum 1:25-32
63. Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann N, Reul JMHM, Landgraf R, Holsboer F (1995) Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucucorticoid receptor function. J Neuroendocrinol 7:841-845
64. Overmeier JB, Seligman MEP (1967) Effects of inescapable shock upon subsequent escape and avoidable responding. J Comp Physiol Psychol 63 23-33
65. 63a. Owens MJ, Nemeroff CB (1993) The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found Symp 172:296-316
66. Pepin MC, Govidan MV, Barden N (1992) Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol Pharmacol 42:991-995
67. Pepin MC, Pothier F, Barden N (1992) Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 41:1016-1022
68. Pihoker C, Owens MJ, Kuhn CM, Schanberg SM, Nameroff CB (1993) Maternal separation in neonatal rat elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for corticotropin-releasing factor. Psychoneuroendocrinology 18 485-493
69. Post RM, Rubinow DR, Ballenger JC (1986) Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry 149:191-201
70. Prien RF, Kupfer DJ (1986) Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 143:18-23
71. Reul JMH, Stec I, Soder M, Holsboer F (1993) Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamin-pituitary-adrenocortical system. Endocrinology 133:312-320
72. Reul JMH, Stec I, Wiegers JG, Labeur MS, Lindhorst AC, Arzt E, Holsboer F (1994) Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats. J Clin Invest 93 2600-2607
73. Riemann D, Berger M (1992) Sleep, age, depression and the cholinergic REM-induction test with RS 86. Prog Neuropsychopharmacol Biol Psychiatry 16:311-316
74. Rupprecht R, Reul JM, Trapp T, van Steenset B, Wetzel C, Damm K, Zieglgansberger W, Holsboer F (1993) Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11:523-530
75. Rush AJ, Ermann MK, Giles DE, Schlesser MA, Carpenter G, Vasavada H, Roffwarg HP (1986) Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry 43:878-884
76. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF (1973) Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 19-24
77. Salmoriaghi GC, Bloom FE (1964) Science 144:493
78. Schreiber W, Lauer C, Krieg J, Krumrey K, Holsboer F (1992) REM sleep desinhibition after cholinergic challenge in subjects at high risk for psychiatric disorders. Biol Psychiatry 330:79-90
79. Simson PE, Weiss JM (1988) Altered activity of the locus ceruleus in an animal model of depression. Neuropsychopharmacology 1:287-295
80. Sitaram N, Nurnberger JI, Gershon ES (1980) Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. Science 20:200-201
81. Sitaram S, Dube S, Keshavan M, Davies A, Reynal P (1997) The association of supersensitive cholinergic REM-induction and affective illness within pedigrees. J Psychiat Res 21:487-497
82. Stassen HH, Delini-Stula A, Angst J (1993) Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol 3:127-135
83. 80a. Stenzel-Poore MP, Heinnchs SC, Rivest S, Koob GF, Vale WW (1994) Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neuroscience 14-2579-2584
84. Stewart KT, McEachron DL, Rosenwasser AM, Adler NT (1991) Lithium lengthens circadian period but fails to counteract behavioral helplessness in rats. Biol Psychiatry 30.515-518
85. Stokes PE (1993) Fluoxetin, a five year survey. Clin Ther 15.216-243
86. Sutton RE, Koob GF, LeMoal M, Rivier J, Vale W (1982) Corticotropin releasing factor (CRF) produces behavioural activation in rats. Nature 297:331-333
87. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36.165-186
88. Teicher MH, Glod CA, Surrey J, Swett C (1993) Early childhood abuse and limbic system ratings in adult psychiatric outpatients. J Neuropsychiatr Clin Neurosci 5:301-306
89. Tellenbach H (1974) Melancholia. Springer, Berlin Heidelberg New York
90. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394-1397
91. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J (1983) Chemical and biological characterization of corticotropin releasing factor. Rec Proc Horm Res 39:245-270
92. Valentino RJ, Foote SL, Aston-Jones G (1983) CRF activates noradrenergic neurons of the lotus coeruleus. Brain Res 270:363-367
93. Vidai C, Jordan W, Zieglgansberger W (1986) Corticosterone reduces the excitability of hippocampal pyramidal cells in vitro. Brain Res 383:54-59
94. Vollmayr B, Aldenhoff JB (1994) Cytosolic free [Ca2+] in single T-lymphocytes from depressed patients and healthy controls. Eur Arch Psychiatry Clin Neurosci 243:214-217
95. Yehuda R, Giller EL, Mason JW (1993) Psychoneuroendocrine assessment of posttraumatic stress disorder: current progress and new directions. Prog Neuropsychopharmacol Biol Psychiatry 17:541-550
96. Young EA, Haskett RF, Murphy-Weinberg V, Watson SJ, Akil H (1991) Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 48:693-699